132 related articles for article (PubMed ID: 10205763)
1. [Active hepatitis B vaccination in ulcerative colitis treated with azathioprine].
Hinrichsen H; Fölsch UR
Internist (Berl); 1999 Mar; 40(3):327-8. PubMed ID: 10205763
[No Abstract] [Full Text] [Related]
2. [Azathioprine also in chronic active ulcerative colitis. Brake pedal for the immune system].
MMW Fortschr Med; 2000 Mar; 142(12):58-9. PubMed ID: 10804723
[No Abstract] [Full Text] [Related]
3. Azathioprine dose escalation in inflammatory bowel disease.
Rayner CK; Hart AL; Hayward CM; Emmanuel AV; Kamm MA
Aliment Pharmacol Ther; 2004 Jul; 20(1):65-71. PubMed ID: 15225172
[TBL] [Abstract][Full Text] [Related]
4. 6-tioguanine monitoring in steroid-dependent patients with inflammatory bowel diseases receiving azathioprine.
Roblin X; Serre-Debeauvais F; Phelip JM; Faucheron JL; Hardy G; Chartier A; Helluwaert F; Bessard G; Bonaz B
Aliment Pharmacol Ther; 2005 Apr; 21(7):829-39. PubMed ID: 15801918
[TBL] [Abstract][Full Text] [Related]
5. Low-dose azathioprine is effective and safe for maintenance of remission in patients with ulcerative colitis.
Hibi T; Naganuma M; Kitahora T; Kinjyo F; Shimoyama T
J Gastroenterol; 2003; 38(8):740-6. PubMed ID: 14505127
[TBL] [Abstract][Full Text] [Related]
6. Impaired antibody response rates after high dose short interval hepatitis B virus vaccination of immunosuppressed individuals.
Idilman R; Colantoni A; De Maria N; Ustun C; Sam R; Ing TS; Akan H; Koc H; Van Thiel DH
Hepatogastroenterology; 2003; 50(49):217-21. PubMed ID: 12630026
[TBL] [Abstract][Full Text] [Related]
7. The 17-year single-center experience with the use of azathioprine to maintain remission in ulcerative colitis.
Actis GC; Fadda M; Pellicano R; David E; Rizzetto M; Sapino A
Biomed Pharmacother; 2009 Jun; 63(5):362-5. PubMed ID: 18657949
[TBL] [Abstract][Full Text] [Related]
8. Intravenous azathioprine in severe ulcerative colitis: a pilot study.
Mahadevan U; Tremaine WJ; Johnson T; Pike MG; Mays DC; Lipsky JJ; Sandborn WJ
Am J Gastroenterol; 2000 Dec; 95(12):3463-8. PubMed ID: 11151878
[TBL] [Abstract][Full Text] [Related]
9. Diffuse febrile dermatosis in a patient with active ulcerative colitis under treatment with steroids and azathioprine: a case of Sweet's syndrome. Case report and review of literature.
Paoluzi OA; Crispino P; Amantea A; Pica R; Iacopini F; Consolazio A; Di Palma V; Rivera M; Paoluzi P
Dig Liver Dis; 2004 May; 36(5):361-6. PubMed ID: 15191207
[TBL] [Abstract][Full Text] [Related]
10. [Ulcerative colitis. Chronic active course].
Dignass AU; Herrlinger K; Schölmerich J
Z Gastroenterol; 2004 Sep; 42(9):1006-10. PubMed ID: 15455274
[No Abstract] [Full Text] [Related]
11. [Hodgkin's disease developing in the course of a chronic liver disease with ulcerative colitis immunosuppressed with azathioprine].
Orbuch SJ; Findor JA
Acta Gastroenterol Latinoam; 1979; 9(2):73-80. PubMed ID: 506643
[TBL] [Abstract][Full Text] [Related]
12. A case of interstitial pneumonitis in a patient with ulcerative colitis treated with azathioprine.
Nagy F; Molnar T; Makula E; Kiss I; Milassin P; Zollei E; Tiszlavicz L; Lonovics J
World J Gastroenterol; 2007 Jan; 13(2):316-9. PubMed ID: 17226917
[TBL] [Abstract][Full Text] [Related]
13. Mathematical model of the antibody response to hepatitis B vaccines: implications for reduced schedules.
Wilson JN; Nokes DJ; Medley GF; Shouval D
Vaccine; 2007 May; 25(18):3705-12. PubMed ID: 17306427
[TBL] [Abstract][Full Text] [Related]
14. Low-dose intramuscular hepatitis B vaccination in medical students: 4-year follow-up.
Erensoy S; Bilgiç A; Arda B; Ozer O
Infection; 2002 Oct; 30(5):303-5. PubMed ID: 12382091
[TBL] [Abstract][Full Text] [Related]
15. Oral methotrexate in ulcerative colitis.
Cummings JR; Herrlinger KR; Travis SP; Gorard DA; McIntyre AS; Jewell DP
Aliment Pharmacol Ther; 2005 Feb; 21(4):385-9. PubMed ID: 15709988
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus serologic markers and anti-hepatitis B vaccination in patients with diabetes.
Halota W; Muszyńska M; Pawłowska M
Med Sci Monit; 2002 Jul; 8(7):CR516-9. PubMed ID: 12118201
[TBL] [Abstract][Full Text] [Related]
17. [Azathioprine].
Sasaki M; Fujiyama Y
Nihon Rinsho; 2005 May; 63 Suppl 5():692-9. PubMed ID: 15954431
[No Abstract] [Full Text] [Related]
18. [Hepatitis B vaccination in patients on chronic hemodialysis].
Kovacić V; Sain M; Vukman V
Lijec Vjesn; 2003; 125(5-6):156-8. PubMed ID: 14533468
[TBL] [Abstract][Full Text] [Related]
19. Influence of circadian rhythm on the efficacy of the hepatitis B vaccination.
Karabay O; Temel A; Koker AG; Tokel M; Ceyhan M; Kocoglu E
Vaccine; 2008 Feb; 26(9):1143-4. PubMed ID: 18255201
[No Abstract] [Full Text] [Related]
20. Choice of azathioprine or 6-mercaptopurine dose based on thiopurine methyltransferase (TPMT) activity to avoid myelosuppression. A prospective study.
Gisbert JP; Luna M; Maté J; González-Guijarro L; Cara C; Pajares JM
Hepatogastroenterology; 2006; 53(69):399-404. PubMed ID: 16795981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
